| All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients N Mirza, M Fishman, I Fricke, M Dunn, AM Neuger, TJ Frost, RM Lush, ... Cancer research 66 (18), 9299-9307, 2006 | 669 | 2006 |
| Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer SJ Antonia, N Mirza, I Fricke, A Chiappori, P Thompson, N Williams, ... Clinical cancer research 12 (3), 878-887, 2006 | 548 | 2006 |
| Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses I Fricke, N Mirza, J Dupont, C Lockhart, A Jackson, JH Lee, JA Sosman, ... Clinical Cancer Research 13 (16), 4840-4848, 2007 | 212 | 2007 |
| Dendritic cells and tumor microenvironment: a dangerous liaison I Fricke, DI Gabrilovich Immunological investigations 35 (3-4), 459-483, 2006 | 190 | 2006 |
| Mycobacteria induce IFN-γ production in human dendritic cells via triggering of TLR2 I Fricke, D Mitchell, J Mittelstädt, N Lehan, H Heine, T Goldmann, ... The Journal of Immunology 176 (9), 5173-5182, 2006 | 109 | 2006 |
| Platelet factor 4 in conjunction with IL‐4 directs differentiation of human monocytes into specialized antigen‐presenting cells I Fricke, D Mitchell, F Petersen, A Böhle, S Bulfone‐Paus, S Brandau The FASEB journal 18 (13), 1588-1590, 2004 | 63 | 2004 |
| Localization of Cold Shock Proteins to Cytosolic Spaces Surrounding Nucleoids in Bacillus subtilis Depends on Active Transcription MHW Weber, AV Volkov, I Fricke, MA Marahiel, PL Graumann Journal of bacteriology 183 (21), 6435-6443, 2001 | 55 | 2001 |
| Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma SE Finkelstein, T Carey, I Fricke, D Yu, D Goetz, M Gratz, M Dunn, ... Journal of immunotherapy 33 (8), 817-827, 2010 | 48 | 2010 |
| CSDBase: an interactive database for cold shock domain-containing proteins and the bacterial cold shock response MHW Weber, I Fricke, N Doll, MA Marahiel Nucleic acids research 30 (1), 375-378, 2002 | 31 | 2002 |
| Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms B Brown, V Ojha, I Fricke, SA Al-Sheboul, C Imarogbe, T Gravier, M Green, ... Vaccines 11 (2), 408, 2023 | 17 | 2023 |
| An immunological review of SARS-CoV-2 infection and vaccine serology: innate and adaptive responses to mRNA, adenovirus, inactivated and protein subunit vaccines SA Al-Sheboul, B Brown, Y Shboul, I Fricke, C Imarogbe, KH Alzoubi Vaccines 11 (1), 51, 2022 | 12 | 2022 |
| Immunopathogenesis of Nipah virus infection and associated immune responses B Brown, T Gravier, I Fricke, SA Al-Sheboul, TN Carp, CY Leow, ... Immuno 3 (2), 160-181, 2023 | 6 | 2023 |
| M17-02: Immunotherapy of extensive stage small cell lung cancer with dendritic cell based p53 vaccine S Antonia, N Mirza, A Chiappori, I Fricke, G Bepler, G Simon, W Janssen, ... Journal of Thoracic Oncology 2 (8), S198-S199, 2007 | 3 | 2007 |
| Cellular and Humoral Immunity and Infection Responses to SARS-CoV-2: Immune Biomolecular Mechanisms by Case Study within SARS-CoV-2 Pathogenesis and Other Infections B Brown, V Ojha, I Fricke, M Green, C Imarogbe, SA Al-Sheboul, T Gravier, ... Preprints, 2022 | 2 | 2022 |
| Immunopathogenesis of Orthopoxviridae: insights into immunology from smallpox to monkeypox (mpox) B Brown, C Imarogbe, I Fricke, A Gonzalez, P Mensah Preprints, 2023 | 1 | 2023 |
| Filoviridae: Insights into Immune Responses to Ebolavirus B Brown, C Imarogbe, T Gravier, I Fricke, T Lucas Available at SSRN 4502454, 2023 | 1 | 2023 |
| Dendritic cell and myeloid derived suppressor changes with interleukin-2 therapeutic administration SE Finkelstein, D Gabrilovich, T Carey, I Fricke, D Yu, M Dunn, A Daud, ... JOURNAL OF IMMUNOTHERAPY 33 (8), 877-877, 2010 | 1 | 2010 |
| A new vaccine approach and convalescent plasma until its development I Fricke, SN Freeman https://doi.org/10.31219/osf.io/msu98, 2020 | | 2020 |
| VEGF-Trap (VT) overcomes defects in dendritic cell (DC) differentiation without improvement in antigen-specific immune responses JA Sosman, I Fricke, N Mirza, J Dupont, AC Lockhart, A Jackson, ... Journal of Clinical Oncology 25 (18_suppl), 21087-21087, 2007 | | 2007 |
| Murine dendritic cells are not impaired by interaction with Gr1+-cells I Fricke, DI Gabrilovich JOURNAL OF IMMUNOLOGY 176, S277-S278, 2006 | | 2006 |
Dmitry GabrilovichChief Scientist, Cancer Immunology, AstraZenecaVerified email at astrazeneca.com
